These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1812716)

  • 1. X-ray analysis of a difluorostatone renin inhibitor bound as the tetrahedral hydrate to the aspartic protease endothiapepsin.
    Hoover DJ; Veerapandian B; Cooper JB; Damon DB; Dominy BW; Rosati RL; Blundell TL
    Adv Exp Med Biol; 1991; 306():269-73. PubMed ID: 1812716
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
    Veerapandian B; Cooper JB; Sali A; Blundell TL; Rosati RL; Dominy BW; Damon DB; Hoover DJ
    Protein Sci; 1992 Mar; 1(3):322-8. PubMed ID: 1304340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
    Veerapandian B; Cooper JB; Sali A; Blundell TL
    J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
    Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
    Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
    J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors.
    Cooper J; Quail W; Frazao C; Foundling SI; Blundell TL; Humblet C; Lunney EA; Lowther WT; Dunn BM
    Biochemistry; 1992 Sep; 31(35):8142-50. PubMed ID: 1525155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain flexibility in aspartic proteinases.
    Sali A; Veerapandian B; Cooper JB; Moss DS; Hofmann T; Blundell TL
    Proteins; 1992 Feb; 12(2):158-70. PubMed ID: 1603805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neutron Laue diffraction study of endothiapepsin: implications for the aspartic proteinase mechanism.
    Coates L; Erskine PT; Wood SP; Myles DA; Cooper JB
    Biochemistry; 2001 Nov; 40(44):13149-57. PubMed ID: 11683623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional X-ray crystal structure of the aspartic proteinase native to Trichoderma reesei complexed with a renin inhibitor CP-80794.
    Pitts JE; Crawford MD; Nugent PG; Wester RT; Cooper JB; Mantyla A; Fagerstrom R; Nevalainen H
    Adv Exp Med Biol; 1995; 362():543-7. PubMed ID: 8540369
    [No Abstract]   [Full Text] [Related]  

  • 10. Analyses of ligand binding in five endothiapepsin crystal complexes and their use in the design and evaluation of novel renin inhibitors.
    Lunney EA; Hamilton HW; Hodges JC; Kaltenbronn JS; Repine JT; Badasso M; Cooper JB; Dealwis C; Wallace BA; Lowther WT
    J Med Chem; 1993 Nov; 36(24):3809-20. PubMed ID: 8254610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.
    Sali A; Veerapandian B; Cooper JB; Foundling SI; Hoover DJ; Blundell TL
    EMBO J; 1989 Aug; 8(8):2179-88. PubMed ID: 2676515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes.
    Foundling SI; Cooper J; Watson FE; Cleasby A; Pearl LH; Sibanda BL; Hemmings A; Wood SP; Blundell TL; Valler MJ
    Nature; 1987 May 28-Jun 3; 327(6120):349-52. PubMed ID: 3295561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary neutron Laue diffraction study of the aspartic proteinase endothiapepsin.
    Cooper JB; Myles DA
    Acta Crystallogr D Biol Crystallogr; 2000 Feb; 56(Pt 2):246-8. PubMed ID: 10666618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending crystallographic information with semiempirical quantum mechanics and molecular mechanics: a case of aspartic proteinases.
    Goldblum A; Rayan A; Fliess A; Glick M
    J Chem Inf Comput Sci; 1993; 33(2):270-4. PubMed ID: 8391019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three-dimensional structure at 2.4 A resolution of glycosylated proteinase A from the lysosome-like vacuole of Saccharomyces cerevisiae.
    Aguilar CF; Cronin NB; Badasso M; Dreyer T; Newman MP; Cooper JB; Hoover DJ; Wood SP; Johnson MS; Blundell TL
    J Mol Biol; 1997 Apr; 267(4):899-915. PubMed ID: 9135120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
    Hartman AM; Mondal M; Radeva N; Klebe G; Hirsch AK
    Int J Mol Sci; 2015 Aug; 16(8):19184-94. PubMed ID: 26287174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of rhizopuspepsin/inhibitor complexes.
    Parris KD; Hoover DJ; Davies DR
    Adv Exp Med Biol; 1991; 306():217-31. PubMed ID: 1812709
    [No Abstract]   [Full Text] [Related]  

  • 18. The structure of endothiapepsin complexed with the gem-diol inhibitor PD-135,040 at 1.37 A.
    Coates L; Erskine PT; Mall S; Williams PA; Gill RS; Wood SP; Cooper JB
    Acta Crystallogr D Biol Crystallogr; 2003 Jun; 59(Pt 6):978-81. PubMed ID: 12777758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural thermodynamic study of the binding of renin inhibitors to endothiapepsin.
    Gómez J; Semo N; Freire E
    Adv Exp Med Biol; 1998; 436():325-8. PubMed ID: 9561236
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents.
    Cooper JB; Foundling SI; Hemmings A; Watson FE; Sibanda BL; Blundell TL; Jones DM; Hallett A; Atrash B; Szelke M
    Biochem Soc Trans; 1987 Aug; 15(4):751-4. PubMed ID: 3119394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.